TD Waterhouse Canada’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.97M Sell
75,765
-4,923
-6% -$412K 0.02% 341
2026
Q1
$6.55M Buy
80,688
+74,447
+1,193% +$6.14M 0.02% 334
2025
Q4
$532K Sell
6,241
-452
-7% -$37.1K ﹤0.01% 683
2025
Q3
$509K Buy
6,693
+539
+9% +$42.1K ﹤0.01% 677
2025
Q2
$475K Buy
6,154
+192
+3% +$14.3K ﹤0.01% 665
2025
Q1
$428K Buy
5,962
+893
+18% +$63.9K ﹤0.01% 660
2024
Q4
$375K Sell
5,069
-2,801
-36% -$196K ﹤0.01% 670
2024
Q3
$512K Buy
7,870
+1,660
+27% +$121K ﹤0.01% 605
2024
Q2
$561K Sell
6,210
-93
-1% -$8.24K 0.01% 579
2024
Q1
$610K Buy
+6,303
New +$529K ﹤0.01% 580

Other funds holding EW

TD Waterhouse Canada's EW Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Edwards Lifesciences (EW) stake by 6.1% in Q2 2026, selling an estimated $412K and leaving 75,765 shares worth $6.97M. The position accounts for 0.02% of the portfolio, ranked #341.

TD Waterhouse Canada first reported a position in EW in Q1 2024 and has held it in 10 quarters since. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • TD Waterhouse Canada held 75,765 shares of Edwards Lifesciences worth $6.97M as of Q2 2026.
  • TD Waterhouse Canada sold 4,923 Edwards Lifesciences shares in Q2 2026, an estimated $412K.
  • Edwards Lifesciences made up 0.02% of TD Waterhouse Canada's portfolio in Q2 2026, its #341 holding.
  • TD Waterhouse Canada first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.